Clinical trials
Phase 3 Myelodysplastic Syndromes trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 2 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| AbbVie | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Li Junmin | 1 |
| Shandong Provincial Hospital | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| TJ Biopharma Co., Ltd. | 1 |
| Takeda | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 12 |
| Leukemia, Myeloid, Acute | 4 |
| Anemia | 2 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Anemia, Diamond-Blackfan | 1 |
| Myeloproliferative Disorders | 1 |
| Neoplasms | 1 |
| Thalassemia | 1 |
| beta-Thalassemia | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.